| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Microbial Chemistry, Shinagawa-ku, Tokyo, Japan
Macromomycin, a proteinaceous antitumor antibiotic, binds to the membrane of tumor cells and thereby preferentially inhibits DNA synthesis. The cytotoxicity could be abolished by removal of macromomycin from the binding locus by a brief treatment with trypsin.
Received 3/22/71. Accepted 2/29/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |